Role of biomarkers in risk stratification of acute coronary syndrome
2010

Role of Biomarkers in Acute Coronary Syndrome

Sample size: 450 publication Evidence: moderate

Author Information

Author(s): Nagesh C.M. Roy, Ambuj

Primary Institution: All India Institute of Medical Sciences, New Delhi, India

Hypothesis

The study explores the role of established and emerging biomarkers in the diagnosis and prognosis of acute coronary syndrome (ACS).

Conclusion

Biomarkers like troponin, BNP, and CRP are crucial in diagnosing and predicting outcomes in ACS, and newer biomarkers may enhance this further.

Supporting Evidence

  • Troponin is a well-established biomarker for diagnosing and predicting outcomes in ACS.
  • BNP and NT-proBNP levels are associated with increased risk of heart failure and death in ACS patients.
  • C-reactive protein levels correlate with the extent of atherosclerosis and predict coronary events.

Takeaway

Doctors use special markers in the blood to see if someone has heart problems. New markers might help them do an even better job.

Methodology

The review discusses various established and emerging biomarkers and their roles in ACS management.

Limitations

The review highlights the need for clinical trials to test the effectiveness and cost-effectiveness of multimarker testing.

Digital Object Identifier (DOI)

10.4103/0971-5916.73419

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication